Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ruben M. Muñoz"'
Publikováno v:
Investigational New Drugs. 19:283-291
Irofulven (hydroxymethylacylfulvene, HMAF, MGI 114) is a novel agent with alkylating activity and a potent inducer of apoptosis. It is currently undergoing Phase II clinical trials for several tumor types, including hormone-refractory prostate cancer
Autor:
Warner, Steven L., Muñoz, Ruben M., Bearss, David J., Grippo, Paul, Han, Haiyong, Von Hoff, Daniel D.
Publikováno v:
Pancreas; Oct2008, Vol. 37 Issue 3, pe39-e44, 6p